Improving glucose and gluamiue metabolism of human HEK 293 and Trchoplusia ni insect cells engineered to express a cytosolic pyruvate carboxylase enzyme

被引:53
作者
Elias, CB
Carpentier, E
Durocher, Y
Bisson, L
Wagner, R
Kamen, A [1 ]
机构
[1] Biotechnol Res Inst, Anim Cell Technol Dept, Montreal, PQ H4P 2R2, Canada
[2] German Res Ctr Biotechnol mbH, Cell Culture Technol Dept, Braunschweig, Germany
关键词
D O I
10.1021/bp025572x
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Metabolic engineering has been defined as a directed improvement of product formation or cellular properties by modification of specific biochemical pathways or introduction of new enzymatic reactions by recombinant DNA technology. The use of metabolic flux analysis (MFA) has helped in the understanding of the key limitation in the metabolic pathways of cultured animal cells. The MFA of the major nutrients glucose and glutamine showed that the flux of glucose to the TCA cycle and its subsequent utilization is limited. as a result of the lack of certain key enzymes in the pathway. One of the key enzymes controlling this flux is pyruvate carboxylase. Introduction of this enzyme into mammalian cells has been shown to improve the utilization of glucose and limit the production of lactate and ammonia, which are deleterious to cell growth. In the present work a yeast pyruvate carboxylase gene has been introduced into mammalian (HEK 293) and insect (Trichoplusia ni High-Five) cells, resulting in the cytosolic expression of the enzyme. In both cases the resulting transfected cells were able to utilize glucose and glutamine more efficiently and produce lower amounts of lactate and ammonia. Differences in the amino acid utilization pattern were also observed, indicating changes in the basic metabolism of the cells. The performance of the transfected cells as expression systems for adenovirus and baculovirus vectors, respectively, has also been examined. The results obtained and their impact on the process development for protein and viral vector production are discussed.
引用
收藏
页码:90 / 97
页数:8
相关论文
共 36 条
[1]  
Andersen Dana C., 1994, Current Opinion in Biotechnology, V5, P546, DOI 10.1016/0958-1669(94)90072-8
[2]   MAXIMIZATION OF RECOMBINANT PROTEIN YIELD IN THE INSECT-CELL BACULOVIRUS SYSTEM BY ONE-TIME ADDITION OF NUTRIENTS TO HIGH-DENSITY BATCH CULTURES [J].
BEDARD, C ;
KAMEN, A ;
TOM, R ;
MASSIE, B .
CYTOTECHNOLOGY, 1994, 15 (1-3) :129-138
[3]   SECRETED PLACENTAL ALKALINE-PHOSPHATASE - A POWERFUL NEW QUANTITATIVE INDICATOR OF GENE-EXPRESSION IN EUKARYOTIC CELLS [J].
BERGER, J ;
HAUBER, J ;
HAUBER, R ;
GEIGER, R ;
CULLEN, BR .
GENE, 1988, 66 (01) :1-10
[4]   Metabolic-flux analysis of continuously cultured hybridoma cells using 13CO2 mass spectrometry in combination with 13C-lactate nuclear magnetic resonance spectroscopy and metabolite balancing [J].
Bonarius, HPJ ;
Özemre, A ;
Timmerarends, B ;
Skrabal, P ;
Tramper, J ;
Schmid, G ;
Heinzle, E .
BIOTECHNOLOGY AND BIOENGINEERING, 2001, 74 (06) :528-538
[5]   Study of adenovirus production in serum-free 293SF suspension culture by GFP-expression monitoring [J].
Cote, J ;
Bourget, L ;
Garnier, A ;
Kamen, A .
BIOTECHNOLOGY PROGRESS, 1997, 13 (06) :709-714
[6]   High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells [J].
Durocher, Y ;
Perret, S ;
Kamen, A .
NUCLEIC ACIDS RESEARCH, 2002, 30 (02) :E9
[7]   GLUCOSE AND GLUTAMINE-METABOLISM OF A MURINE B-LYMPHOCYTE HYBRIDOMA GROWN IN BATCH CULTURE [J].
FITZPATRICK, L ;
JENKINS, HA ;
BUTLER, M .
APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 1993, 43 (02) :93-116
[8]   MATHEMATICAL DESCRIPTIONS OF HYBRIDOMA CULTURE KINETICS .3. SIMULATION OF FED-BATCH BIOREACTORS [J].
GLACKEN, MW ;
HUANG, C ;
SINSKEY, AJ .
JOURNAL OF BIOTECHNOLOGY, 1989, 10 (01) :39-65
[9]   Expression of recombinant cytoplasmic yeast pyruvate carboxylase for the improvement of the production of human erythropoietin by recombinant BHK-21 cells [J].
Irani, N ;
Beccaria, AJ ;
Wagner, R .
JOURNAL OF BIOTECHNOLOGY, 2002, 93 (03) :269-282
[10]  
Irani N, 1999, BIOTECHNOL BIOENG, V66, P238, DOI 10.1002/(SICI)1097-0290(1999)66:4<238::AID-BIT5>3.0.CO